Mergen, Oxford Gene Technology Settle Patent Infringement Suit

Law360, New York (January 20, 2005, 12:00 AM EST) -- Biotech company Mergen Ltd. has agreed to take a license to settle U.K.-based Oxford Gene Technology’s patent infringement lawsuit, the company said.

Under the terms of the settlement, Mergen has obtained a license from OGT for its expression chips in the U.S., Europe and Japan. This license allows Mergen to manufacture and sell microarrays, the company said.

Financial terms of the settlement agreeement were not revealed.

“We believe that this license will give Mergen valuable freedom to operate and grow its expression profiling oligo microarray business...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.